Iron Overload Due to Transfusion
📧 Sign up to get email alerts when something new happens for Iron Overload Due to Transfusion.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-03-09FDA Approved: DEFERASIROX ORAL GRANULES — Original Application (EPIC PHARMA, LLC)
FDA approved Deferasirox oral granules as an original generic application for treating chronic iron overload due to transfusion in patients …
-
FDA approval · 2020-06-15FDA Approved: DEFERASIROX — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves a generic version of deferasirox (Zydus Pharmaceuticals USA) under ANDA211383 for chronic iron overload due to blood transfusio…
-
FDA approval · 2018-08-03FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for JADENU (deferasirox) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2018-01-26FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for JADENU (deferasirox) from Novartis Pharmaceuticals, authorizing changes to its labeling rela…